X

Trial Profile

Phase III, Randomized, Multicenter, Controlled Evaluation of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 07 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
Indications Adenocarcinoma; Gastric cancer
Focus Therapeutic Use
Acronyms RESONANCE

Most Recent Events

25 Jan 2020 Status changed from recruiting to active, no longer recruiting as per results presented at the 2020 Gastrointestinal Cancers Symposium
25 Jan 2020 Results presented at the 2020 Gastrointestinal Cancers Symposium
12 Sep 2017 Results (n=420) presented at the 42nd European Society for Medical Oncology Congress

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com